相关实验视频
Updated: Jan 28, 2026

11:45
Quantifying Agonist Activity at G Protein-coupled Receptors
Published on: December 26, 2011
19.8K
GLP-1受体激动剂和有意识的镇静作用
Eric K Holder1, Amelia Ni2, David Levi3
1Yale University, Department of Orthopaedics and Rehabilitation, New Haven, CT, USA.
Interventional pain medicine
|January 26, 2026
概括
接受葡萄糖类-1受体激活剂 (GLP-1RA) 的患者可以在选择性疼痛手术期间继续治疗. 彻底的风险评估和共享决策对于周边程序GLP-1RA管理至关重要.
科学领域:
- 疼痛管理 疼痛管理
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 葡萄糖类-1受体激动剂 (GLP-1RA) 越来越多地用于2型糖尿病和肥胖症.
- 选择性疼痛手术需要仔细考虑药物管理.
- 对GLP-1RA治疗的周围程序管理尚未得到普遍标准化.
研究的目的:
- 总结证据,并为接受选择性疼痛手术的GLP-1RA治疗患者的管理提供建议.
- 为了指导临床医生对GLP-1RA用户的周边程序决策.
主要方法:
- 审查当前的多社会指导声明.
- 证据的总结和综合.
- 制定临床建议. 开发临床建议.
主要成果:
- 没有特定风险因素的患者通常可以在周围过程期间继续GLP-1RA治疗.
- 综合性风险评估和共享决策至关重要.
- 意识镇静应该根据具体情况进行评估,并且往往是不必要的.
结论:
- 围绕程序的GLP-1RA管理应该是个性化的.
- 患者,处方团队,执行医生和麻醉师之间的合作至关重要.
- 建议尽量减少不必要的干预,如有意识的镇静.
相关概念视频
Glucagon-like Receptor Agonists
898
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
898
Drug-Receptor Interaction: Agonist
4.0K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.0K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
949
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
949
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
493
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
493
Sedatives and Hypnotics: Overview
1.5K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.5K
Sedatives and Hypnotics Drugs: Barbiturates
1.0K
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
1.0K

